-
Mashup Score: 1Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high‐incidence country - 9 month(s) ago
What’s new? With one of the world’s highest incidences of gallbladder cancer, Chile has been implementing a gallbladder cancer prevention program based on prophylactic cholecystectomy for gallstone p…
Source: onlinelibrary.wiley.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023 - 9 month(s) ago
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Source: jnccn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Read about the latest #NCCNGuidelines recommendations for treatment of #gallbladdercancer, intrahepatic #cholangiocarcinoma, and extrahepatic cholangiocarcinoma in the @NCCN Guidelines Insights for #BiliaryTractCancer: https://t.co/7oAy1k5IPK #hpbcsm Earn free #CME #CNE #CPE https://t.co/HBG4s0rR3a
-
-
Mashup Score: 0Volume of Liver Resected During Gallbladder Surgery May Not Significantly Affect Overall Survival in Patients With Gallbladder Cancer - The ASCO Post - 10 month(s) ago
“When the surgery to remove gallbladder cancer is successful and all the cancer is removed, the amount of [the] liver that is removed doesn’t seem to make a big difference in how long patients live,” said lead study author Eduardo Vega, MD, Assistant Professor of Surgery at the Boston University Chobanian & Avedisian School of Medicine and a hepato-pancreato-biliary surgeon in the Department of Surgery at the Saint Elizabeth Medical Center. In the new study, the investigators sought to address the lack
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Volume of Liver Resected During Gallbladder Surgery May Not Significantly Affect Overall Survival in Patients With Gallbladder Cancer https://t.co/nXuAbUtuQd #hpbcsm #gallbladdercancer #oncology
-
-
Mashup Score: 0High Level of Gallbladder Cancer Surgery Complications According to New Benchmarks - 10 month(s) ago
This study aims to evaluate the quality of gallbladder cancer surgery programmes at different centres through established benchmark values…
Source: European Medical JournalCategories: Gastroenterology, Latest HeadlinesTweet-
New data shows that one-fifth of patients who underwent gallbladder cancer surgery at top-performing centres experienced post-operative complications within 90 days. Learn more with @EMJReviews 👉 https://t.co/SXA66nmrvu #GallbladderCancer #CancerSurgery #CancerCare
-
-
Mashup Score: 1JNCCN 360 - Hepatobiliary - ASCO 2023: Consolidation Chemoradiotherapy Versus Observation After Chemotherapy for Gallbladder Cancer - 11 month(s) ago
By: Julia Fiederlein Cipriano Posted: Thursday, June 15, 2023 Data are limited regarding the oncologic value of consolidation chemoradiation therapy in patients with unresectable, advanced gallbladder cancer who responded to first-line chemotherapy. The results of the RACE-GB study, which were presented by Sushma…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ASCO23: Consolidation Chemoradiotherapy Versus Observation After Chemotherapy for #GallbladderCancer: https://t.co/vuU83aHqkE #HPBCSM #JNCCN360 https://t.co/DNkXt2yVwl
-
-
Mashup Score: 0
CHICAGO — Zanidatamab induced durable responses among patients with previously treated HER2-amplified biliary tract cancer, according to study results presented at ASCO Annual Meeting.The agent also exhibited a manageable safety profile, investigators who conducted the phase 2b HERIZON-BTC-01 study concluded.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Zanidatamab induced durable responses among patients with previously treated HER2-amplified biliary tract cancer. Healio spoke with @DrShubhamPant of @MDAndersonNews about the implications of these results. #ASCO23 #gallbladdercancer https://t.co/cYKDTGCCUZ
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Robotic Hepatic #Bisegmentectomy (s4b + s5) and Hilar #Lymphadenectomy for Incidental #GallbladderCancer Using Glissonian Approach https://t.co/4NvWupBtwP #VisualAbstract https://t.co/emejTBtJTH
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
From This Month's @AnnSurgOncol Issue: #AdjuvantChemoradiation in Patients with Lymph Node-Positive #BiliaryTractCancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809) #extrahepaticcholangiocarcinoma #gallbladdercancer https://t.co/BjzvsjFmcs @McMastersKelly https://t.co/VDE3fS6LRH
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
MARCH ISSUE: #AdjuvantChemoradiation in Patients with Lymph Node-Positive #BiliaryTractCancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809) #extrahepaticcholangiocarcinoma #gallbladdercancer https://t.co/mHilXyiuke @McMastersKelly @SocSurgOnc https://t.co/mxzcGiR4di
-
-
Mashup Score: 3
Understanding the lifestyle factors that contribute to the onset of biliary tract cancers may ultimately help lower risk.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI: Research is advancing new treatments for #gallbladdercancer and #bileductcancer. Learn more on the #AACRBlog: https://t.co/QIF2erWeW8 #cholangiocarcinoma https://t.co/V0DT76ME6w
-
📣 #EditorsChoice - Read "Development and internal validation of a multifactorial risk prediction model for #GallbladderCancer in a high-incidence country," available #OpenAccess in @IntJCanc. ➡️ https://t.co/fC7joAvFCo #Oncology #OA https://t.co/Wtr4OyWZMq